PUBLISHER: IMARC | PRODUCT CODE: 1561465
PUBLISHER: IMARC | PRODUCT CODE: 1561465
The global surgical sutures market size reached US$ 5.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.3 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032. Development of advanced suture materials, rapid technological advancements, shifting consumer preference towards minimally invasive surgeries (MIS), inflating consumer per capita income, and burgeoning prevalence of cosmetic surgeries are some of the factors bolstering the market growth.
Escalating chronic diseases prevalence
Globally, the prevalence of chronic diseases in increasing at an unprecedented rate, which has further burgeoned the demand for surgical sutures. As pe the World Health Organization (WHO), about 41 million people die of non-communicable diseases every year, which is equivalent to 74% of all the deaths globally. The escalating prevalence of obesity, diabetes, cardiovascular ailments, and cancers have surged the requirement for surgical interventions, which is further stimulating the market growth. As per the International Diabetes Federation (IDF), by 2045, about 783 million people will be living with diabetes. As these conditions become more common due to factors like aging populations and lifestyle changes, the demand for surgical procedures escalates. Consequently, there's a heightened need for surgical sutures, essential for closing wounds post-surgery.
Development of advanced suture materials
Recent developments in the surgical sutures market have completely changed the wound closure techniques, which is further supporting the market growth. Key market players are developing modern sutures that are more compatible with the human body in order to minimize the risk of infection and promote fast healing. For instance, in May 2023, a team of engineers from the Massachusetts Institute of Technology (MIT) developed "smart" sutures with the potential to benefit Crohn's disease patients undergoing surgery, and could also have applications for drug delivery, sensing inflammation, and cell therapies. These advancements help to improve patient outcomes and also cater to the evolving needs of surgeons, marking a significant leap forward in surgical care.
Burgeoning prevalence of cosmetic surgeries
The inflating consumer per capita income has considerably surged the need to seek aesthetic enhancements, further boosting the demand for cosmetic surgeries, which represents the primary factor propelling the market growth. As per the International Society of Aesthetic Plastic Surgery (ISAPS) in 2020, over 24 million non-surgical and surgical aesthetic procedures were performed globally in 2019. Aesthetic procedures require most precision, which has further burgeoned the requirement for high-quality suture materials to optimal aesthetic outcomes and ensure minimal scarring. The burgeoning cosmetic industry, fueled by societal pressures, media influence, and the desire for self-improvement, has led to a surge in surgical interventions.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, material, application, and end user.
Absorbable sutures accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the type. This includes absorbable sutures and non-absorbable sutures. According to the report, absorbable sutures represented the largest segment.
The absorbable sutures segment is driven by the increasing demand for minimally invasive surgical procedures and the rising preference for absorbable materials due to their ability to break down harmlessly in the body over time, eliminating the need for suture removal. Additionally, advancements in technology leading to the development of absorbable sutures with enhanced tensile strength, flexibility, and biocompatibility further fuel the growth of this segment. For instance, in May 2023, a new nanocomposite coating was developed that can inhibit biofilm formation and also kill attached bacteria, further tackling the surging cases of post-operative infections, caused due to antibiotic resistance in bacteria. As per the WHO, post-operative surgical site infections (SSIs) affect about 11% of patients in low and middle-income countries. They are caused due to the development of biofilms on the incision site or in the soft tissue inside the site. Moreover, the growing incidence of chronic diseases and surgeries, coupled with the expanding geriatric population globally, are propelling the market growth.
Multifilament holds the largest share of the industry
A detailed breakup and analysis of the market based on the material have also been provided in the report. This includes monofilament and multifilament. According to the report, multifilament accounted for the largest market share.
The multifilament segment in the surgical sutures market is driven by the increasing demand for sutures with enhanced flexibility and handling characteristics, particularly in delicate surgical procedures where precise knot tying is essential. Additionally, advancements in manufacturing technologies have allowed for the production of multifilament sutures with improved tensile strength and reduced tissue trauma, thereby boosting their adoption among surgeons. Moreover, the growing prevalence of chronic diseases and the rising number of surgical procedures worldwide are propelling the demand for multifilament sutures, as they offer better wound closure and reduced risk of infection compared to monofilament alternatives. Furthermore, the XYZ segment is witnessing growth due to the escalating focus on patient comfort and faster postoperative recovery, as multifilament sutures are often associated with reduced tissue reaction and inflammation, leading to improved healing outcomes.
Cardiovascular Surgeries represents the leading market segment
The report has provided a detailed breakup and analysis of the market based on the application. This includes cardiovascular surgeries, general surgeries, gynecological surgeries, orthopedic surgeries, ophthalmic surgeries, and others. According to the report, cardiovascular surgeries represented the largest segment.
The cardiovascular surgeries segment in the surgical sutures market is driven by the increasing prevalence of cardiovascular diseases globally, necessitating a rise in surgical interventions to address these conditions. As per the iData Research, about 900,000 cardiovascular procedures were carried out each year in the United States, and the number is projected to reach 1.3 million by 2029. With the growing aging population and lifestyle factors such as unhealthy diets and sedentary lifestyles contributing to the surge in cardiovascular issues, there's a heightened demand for effective suturing materials to ensure optimal wound closure and patient recovery. Additionally, advancements in surgical techniques, including minimally invasive procedures, are fueling the demand for specialized sutures designed to withstand the unique challenges of cardiovascular surgeries, such as high tension and continuous stress on the sutures.
Hospitals and clinics exhibits a clear dominance in the market
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and clinics, ambulatory surgical centers, and others. According to the report, hospitals and clinics accounted for the largest market share.
The hospitals segment is driven by the increasing volume of surgical procedures performed globally, spurred by rising prevalence of obesity and other chronic diseases, aging population, and expanding healthcare infrastructure. As per the WHO, over 43% of adults aged 18 and above were overweight and 16% were living with obesity. Hospitals demand surgical sutures characterized by superior tensile strength, knot security, and biocompatibility to ensure optimal wound closure and minimize post-operative complications. Moreover, advancements in surgical techniques and the adoption of minimally invasive procedures necessitate specialized sutures that enable precise tissue approximation and facilitate faster recovery. As per the National Library of Medicine, in 2017 about 9.8 million inpatient operating room procedures were conducted, from which about 11.1% of these procedures were minimally invasive and 2.5% were robotic-assisted.
North America leads the market, accounting for the largest surgical sutures market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for surgical sutures.
The North America surgical sutures market growth is driven by the burgeoning healthcare expenditure, presence of key market players, and the rising cases of accidents. The region is also backed by the presence of the United States and Canada. The United States has a robust presence of several leading surgical suture companies, such as Stryker Corporation, Medtronic Plc, Boston Scientific Corporation, Ethicon Inc, Zimmer Biomet Holdings Inc, Teleflex Incorporated, and others. As per the American Hospital Association (AHA), the country has around 6,090 hospitals. Industry sources also show that every year, an estimated 48.3 million non-surgical and surgical procedures are performed in the United States. Skin tumor excision, gallbladder and biliary tree treatments, and hernia repairs, in addition to colon and intestine resections, are some of the most common surgical procedures performed by general surgeons.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)